Amgen Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8.62B | 9.90B | 9.56B | 9.17B | 8.15B | 9.09B | 8.50B | 8.39B |
| Cost of Goods Sold | 2.74B | 1.79B | 3.08B | 3.01B | 2.97B | 3.11B | 3.31B | 3.24B |
| Gross Profit | 5.87B | 8.11B | 6.47B | 6.16B | 5.18B | 5.97B | 5.19B | 5.15B |
| R&D Expenses | 1.72B | 2.15B | 1.90B | 1.74B | 1.49B | 1.72B | 1.45B | 1.45B |
| Operating Expenses | 3.21B | 4.16B | 3.95B | 3.51B | 4.00B | 3.66B | 3.15B | 3.24B |
| Operating Income | 2.67B | 3.94B | 2.53B | 2.64B | 1.18B | 2.31B | 2.05B | 1.91B |
| Other Income / Gains | -582.0M | -2.43B | 1.40B | -1.08B | 795.0M | -1.53B | 1.05B | -1.11B |
| Net Income | 1.82B | 1.33B | 3.22B | 1.43B | 1.73B | 627.0M | 2.83B | 746.0M |
| EPS (Diluted) | 3.37 | 2.47 | 5.98 | 2.66 | 3.22 | 1.17 | 5.27 | 1.39 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.682 | 0.819 | 0.678 | 0.672 | 0.636 | 0.657 | 0.611 | 0.614 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 891.0M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 987.0M | 0 | 0 |
| Selling General And Administrative Expenses | 1.60B | 1.94B | 1.72B | 1.69B | 1.69B | 1.88B | 1.63B | 1.78B |
| Other Expenses | -113.0M | 76.0M | 329.0M | 77.0M | 830.0M | 61.0M | 71.0M | 11.0M |
| Cost And Expenses | 5.95B | 5.95B | 7.03B | 6.52B | 6.97B | 6.78B | 6.46B | 6.48B |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 657.0M | 653.0M | 685.0M | 708.0M | 723.0M | 747.0M | 776.0M | 808.0M |
| Depreciation And Amortization | 0 | 1.13B | 1.31B | 1.34B | 1.39B | 1.40B | 1.40B | 1.40B |
| Ebitda | 2.74B | 5.07B | 5.91B | 3.62B | 4.08B | 2.93B | 5.27B | 3.00B |
| Ebitdaratio | 0.318 | 0.513 | 0.619 | 0.395 | 0.501 | 0.322 | 0.62 | 0.358 |
| Operating Income Ratio | 0.309 | 0.398 | 0.264 | 0.288 | 0.145 | 0.254 | 0.241 | 0.228 |
| Income Before Tax | 2.08B | 1.51B | 3.92B | 1.57B | 1.97B | 782.0M | 3.10B | 794.0M |
| Income Before Tax Ratio | 0.242 | 0.153 | 0.41 | 0.171 | 0.242 | 0.086 | 0.365 | 0.095 |
| Income Tax Expense | 265.0M | 181.0M | 705.0M | 136.0M | 243.0M | 155.0M | 271.0M | 48.0M |
| Net Income Ratio | 0.211 | 0.135 | 0.337 | 0.156 | 0.212 | 0.069 | 0.333 | 0.089 |
| Epsdiluted | 3.34 | 2.45 | 5.93 | 2.65 | 3.20 | 1.16 | 5.22 | 1.38 |
| Weighted Average Shs Out | 540.0M | 539.0M | 538.0M | 538.0M | 538.0M | 540.5M | 537.0M | 537.0M |
| Weighted Average Shs Out Dil | 544.0M | 543.0M | 542.0M | 541.0M | 541.0M | 542.0M | 542.0M | 541.0M |